Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Analytical Chemistry|January 27, 2023
Covalent Library Screening by Targeted Mass Spectrometry for Rapid Binding Site IdentificationJim Nonomiya, Ke Sherry Li, Brett M Babin, et al.Chemmedchem|April 1, 2021
Native Mass Spectrometry for the Study of PROTAC GNE-987-Containing Ternary ComplexesLouise M Sternicki, Jim Nonomiya, Miaomiao Liu, et al.Biochemistry|November 23, 2006
Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitorNeil Grodsky, Ying Li, Djamal Bouzida, et al.Journal of Applied Toxicology : JAT|January 11, 2007
Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitorsBart A Jessen, Leo Lee, Tatiana Koudriakova, et al.Bioorganic & Medicinal Chemistry Letters|August 13, 2013
A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitorsWendy Lee, Daniel F Ortwine, Philippe Bergeron, et al.Antimicrobial Agents and Chemotherapy|March 25, 2009
Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseStephanie T Shi, Koleen J Herlihy, Joanne P Graham, et al.Analytical Chemistry|January 6, 2022
High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRASG12C by Intact Protein MS and Targeted MRMKe Sherry Li, John G Quinn, Matthew J Saabye, et al.Molecular Cancer Therapeutics|April 17, 2008
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacyCathy Zhang, Karen Lundgren, Zhengming Yan, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 6, 2020
Characterization of Antineovascularization Activity and Ocular Pharmacokinetics of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GNE-947Xingrong Liu, Xiaorong Liang, Jenninfer LeCouter, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral AnglesBrian S Safina, Richard L Elliott, Andrew K Forrest, et al.Pageof 5